Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
Pick Your Favored kind of salad - 2Eli Lilly to build $6 billion Alabama plant as part of US manufacturing push
- 3With more Moon missions on the horizon, avoiding crowding and collisions will be a growing challenge
- 4What's going around right now? COVID, flu, stomach bug on the rise
- 5New ‘Cloud-9’ object could reveal the secrets of dark matter
- When faith comes under fire: How Iran’s repression of religious minorities has increased
- Commonsense Ways to work on Your Funds with a Restricted Pay
- Instructions to Floss Appropriately and Forestall Gum Sickness
- The EU Is Considering Lifting Tariffs on Chinese Electric Vehicles
- The Manual for Electric Vehicles that will be hot dealers in 2023
- People can't get enough of this couple's Hallmark movie reviews. They don't know the painful backstory.
- 5 Instructive Toy Brands for Youngsters
- Changes to CDC website spark debate over autism and vaccine misinformation
- Step by step instructions to Lessen Your Gamble of Creating Cellular breakdown in the lungs
